Cas 213247-66-6,[2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid

213247-66-6

Post Buying Request

Basic information

Product Name: [2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid
Synonyms: [2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid
CAS NO:213247-66-6
Molecular Formula:
Molecular Weight: 362.328
EINECS: N/A
Product Categories: N/A
Mol File: 213247-66-6.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid(CAS DataBase Reference)
NIST Chemistry Reference: [2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid(213247-66-6)
EPA Substance Registry System: [2-(6-amino-9-phenethyl-9H-purin-8-ylamino)-ethyl]-phosphonic acid(213247-66-6)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 213247-66-6(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

213247-66-6 Suppliers

Recommended suppliersmore

213247-66-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 213247-66-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,3,2,4 and 7 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 213247-66:
(8*2)+(7*1)+(6*3)+(5*2)+(4*4)+(3*7)+(2*6)+(1*6)=106
106 % 10 = 6
So 213247-66-6 is a valid CAS Registry Number.

213247-66-6Upstream product

2041-14-7 (2-aminethyl)phosphonic acid

213247-66-6Downstream Products

213247-66-6Relevant articles and documents

Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics

Dang, Qun,Brown, Brian S.,Liu, Yan,Rydzewski, Robert M.,Robinson, Edward D.,Van Poelje, Paul D.,Reddy, M. Rami,Erion, Mark D.

experimental part, p. 2880 - 2898 (2010/02/28)

Inhibition of FBPase is considered a promising way to reduce hepatic gluconeogenesis and therefore could be a potential approach to treat type 2 diabetes. Herein we report the discovery of a series of purine phosphonic acids as AMP mimics targeting the AM

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 213247-66-6